Skip to main content
Skip to content
Case File
d-28525House OversightOther

Resume of Global Health Project Leader citing coordination with Clinton, Honeywell, USAID, and Ellen Johnson Sirleaf

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #015673
Pages
1
Persons
0
Integrity
No Hash Available

Summary

The passage lists routine humanitarian logistics and fundraising activities with high‑profile names, but provides no concrete allegations, financial irregularities, or misconduct. It offers limited in Arranged medical response to 2010 Haiti earthquake at request of President Clinton’s office Secured corporate jet from Honeywell CEO for emergency supplies Coordinated landing slots and protection fr

This document is from the House Oversight Committee Releases.

View Source Collection

Tags

humanitarian-aidgovernment-coordinationpublicprivate-partnershipprivate-sector-supporthouse-oversightforeign-partnershipglobal-healthphilanthropy
Ask AI about this document

Search 264K+ documents with AI-powered analysis

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
Global Health Project Leader (2002-2015) Planned and executed medical missions with global health experts: Haiti Earthquake Response. At the request of President Clinton’s office, arranged for physicians and medical supplies to be sent with first responders in the days following the earthquake in 2010. Collaborated with Dr. Paul Farmer of Partners in Health to re-open the University Hospital in Port au Prince. e Organized transport of 5 full surgical teams and all required equipment. Over ten days, the teams treated 400 patients and performed 50 surgeries. e Personally requested emergency use of corporate jet from CEO of Honeywell and delivered needed supplies during the early days of the mission. e Communicated with military leaders to obtain necessary landing slots, protection from the 82nd Airborne, and tents from USAID to house patients and orphans. e Negotiated resupply without cost of all supplies and medications provided by Mount Sinai. Liberia Medical Missions. Patients received the first chemotherapy in Liberia and a pap screening clinic was opened in Monrovia in 2014 in response to the large number of advanced stage cancers diagnosed during annual missions. Program continued through 2014, to resume post-Ebola. e Coordinated directly with Liberian President Ellen Johnson Sirleaf and her ministers in 2007, 2008. e Obtained private funding to send 30 physicians, medical students and support personnel to provide medical care and surgical intervention. Director of Strategic Initiatives (2001-2002) Planned and facilitated an 18-month program of events to commemorate the institution’s 150" anniversary, reporting to the Executive Vice President and Board of Trustees. Highlights included: opening ceremony with Mayor Bloomberg, archival retrospective at the Museum of the City of New York, Community Health Day with free medical services and screenings to over 1500 attendees, and an Academic Symposium. e Secured $800,000 in corporate sponsorship across the portfolio of events. e Oversaw contract and filming of documentary video on the history of Mount Sinai Hospital. Assistant Dean for Clinical Trial Operations and Business Development (1998-2001) Designed and managed the Office of Clinical Trials, a key organizational and operational component advancing clinical trials and translational research. Developed strategic and operational plans. Prepared grant applications and negotiated contracts for extramural funding involving federal, industry and non-profit foundations. Attended and organized research conferences. Strengthened overall regulatory compliance and fiscal compliance with third party payors. e Launched marketing and outreach program to convey Mount Sinai’s research capabilities. e Attracted ongoing contracts and right of first refusal in phase III clinical trials (with appropriate patient populations) from Novartis, Smith Kline Beecham, Amgen and Pfizer and other pharmaceutical and biotech companies. e Grew research revenue by increasing clinical trials by 40% and patient enrollment by over 320% annually, from inception. e Secured $12 million in NIH funding and ran program on a $1.5 million budget resulting in a profitable operation beginning in year one. e Facilitated contracts between faculty and pharmaceutical and biotech companies resulting in $500,000 in funding for investigator initiated research projects. e Awarded $5 million grant from the American Heart Association after reworking a previously submitted and unfunded NIH grant proposal. e Attained membership in the Smith Kline Beecham Development Partners Program and $500,000 annually in upfront quarterly payments to ensure consistency among clinical research coordinators. 2

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.